Dermatology
Dermatology practices providing medical, surgical, and cosmetic skin care services including Mohs surgery and injectables.
- 4
- Verticals
Overview
Dermatology practices provide medical, surgical, and cosmetic skin care, including Mohs surgery and cosmetic injectables. It was one of the earliest and most aggressive physician-specialty roll-ups, prized for its blend of recurring medical visits, cash-pay cosmetic upside, and ancillary pathology.
PE-backed dermatology platforms consolidated thousands of practices, though the model has faced some integration and reimbursement headwinds. Cosmetic demand and aging-related skin care underpin durable demand.
Market snapshot
Within Offices of Physicians (NAICS 621111); the Census Bureau does not split physician offices by specialty, so dermatology is not separately sized.
Business model & economics
- Revenue model
- Medical reimbursement plus cash-pay cosmetic and pathology
- Recurring revenue
- Moderate–High — recurring medical and cosmetic visits
- EBITDA margin
- 20–30%
- Capex intensity
- Low
- One of the earliest and hottest specialty roll-ups.
- Recurring medical plus cash-pay cosmetic upside.
- Ancillary pathology enhances economics.
M&A deal context
Who’s acquiring
What’s driving deals
- Continued roll-up of dermatology practices.
- Cosmetic and aging-skin demand.
- Ancillary-pathology economics.
Verticals in this segment
- 4.10.6.1Cosmetic Dermatology Practices
Dermatologists offering injectable, laser, and cosmetic treatments.
- 4.10.6.2Dermatology Management Organizations
PE-backed platforms consolidating dermatology practices.
- 4.10.6.3Medical Dermatology Practices
Practices providing medical skin cancer screening and disease treatment.
- 4.10.6.4Mohs & Surgical Dermatology
Dermatologists performing Mohs micrographic skin cancer surgery.
Find Dermatology acquisition targets
Search Acquisera’s index for companies classified under Dermatology (4.10.6) and build a targeted deal pipeline.
Search companies